CAMBRIDGE NUTRITIONAL SCIENCES PLC Cambridge Nutritional Sciences plc Stock
Equities
ODX
GB00B1VCP282
Medical Equipment, Supplies & Distribution
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.084 GBX | +3.39% |
|
+2.10% | +70.17% |
| Apr. 22 | Cambridge Nutritional Sciences Nonexecutive Chair Steps Down; Successor Named | MT |
| Apr. 22 | Cambridge Nutritional Sciences plc Provides Earnings Guidance for the Year Ended 31 March 2024 | CI |
| Sales 2024 * | 9M 11.26M | Sales 2025 * | - | Capitalization | 9.4M 11.76M |
|---|---|---|---|---|---|
| Net income 2024 * | -1M -1.25M | Net income 2025 * | - | EV / Sales 2024 * | 0.58 x |
| Net cash position 2024 * | 4.2M 5.26M | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
| P/E ratio 2024 * |
-7.9
x | P/E ratio 2025 * |
-
| Employees | 91 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.83% |
More Fundamentals
* Assessed data
More news
Latest transcript on Cambridge Nutritional Sciences plc
More press releases
| 1 day | +3.39% | ||
| 1 week | +2.10% | ||
| Current month | +18.38% | ||
| 1 month | +20.12% | ||
| 3 months | +70.17% | ||
| 6 months | +85.64% | ||
| Current year | +70.17% |
1 week
3.70
4.17
1 month
3.204.17
Current year
2.304.17
1 year
1.664.17
3 years
1.6688.80
5 years
1.66126.95
10 years
1.66126.95
| Managers | Title | Age | Since |
|---|---|---|---|
Jag Grewal
CEO | Chief Executive Officer | 54 | 11-06-29 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jag Grewal
CEO | Chief Executive Officer | 54 | 11-06-29 |
Jeremy Millard
BRD | Director/Board Member | 53 | 19-02-28 |
Carolyn Rand
CHM | Chairman | 60 | 23-08-16 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-02 | 4.084 | +3.39% | 41 999 |
| 24-05-01 | 3.95 | +1.28% | 137,118 |
| 24-04-30 | 3.9 | -1.27% | 162,099 |
| 24-04-29 | 3.95 | +2.60% | 1,178,848 |
| 24-04-26 | 3.85 | 0.00% | 623,930 |
Delayed Quote London S.E., May 02, 2024 at 04:59 am EDT
More quotes
Cambridge Nutritional Sciences plc is a United Kingdom-based specialist medical diagnostics company. The Company develops, manufactures and markets diagnostic products associated with food sensitivity and gut health. The Company serves healthcare professionals and the consumer directly with a focus on health and nutrition products.
Calendar
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +70.17% | 11.74M | |
| -9.59% | 7.67B | |
| +1.67% | 5.41B | |
| +8.69% | 4.62B | |
| +0.02% | 4.57B | |
| -51.89% | 3.22B | |
| +6.42% | 2.59B | |
| -13.41% | 2.05B | |
| -8.29% | 1.79B | |
| +1.67% | 1.76B |
- Stock Market
- Equities
- ODX Stock
